Cancer can alter the function and proliferation of megakaryocytes. Tumors can release cytokines and growth factors, such as IL-6 and thrombopoietin, which stimulate megakaryocyte proliferation. This often results in thrombocytosis, a condition characterized by an elevated platelet count that can contribute to a hypercoagulable state, increasing the risk of thrombosis in cancer patients.
